메뉴 건너뛰기




Volumn 15, Issue 1, 2012, Pages 32-44

Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants

Author keywords

Comorbidity; Fibromyalgia; Pregabalin; Treatment patterns; Tricyclic antidepressants

Indexed keywords

ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; BUTORPHANOL; CAPSAICIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYPNOTIC SEDATIVE AGENT; LIDOCAINE; MUSCLE RELAXANT AGENT; NALBUPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PENTAZOCINE; PREGABALIN; SALICYLIC ACID DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE;

EID: 84856055593     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2011.629263     Document Type: Article
Times cited : (12)

References (47)
  • 1
    • 38149052992 scopus 로고    scopus 로고
    • National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II
    • Lawrence RC, Felson DT, Helmick CG, et al. National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35
    • (2008) Arthritis Rheum , vol.58 , pp. 26-35
    • Lawrence, R.C.1    Felson, D.T.2    Helmick, C.G.3
  • 3
    • 0027504013 scopus 로고
    • The epidemiology of fibromyalgia
    • DOI 10.1300/J094v01n03-11
    • Wolfe F. The epidemiology of fibromyalgia. J Musculoskelet Pain 1993; 1:137-48 (Pubitemid 23323898)
    • (1993) Journal of Musculoskeletal Pain , vol.1 , Issue.3-4 , pp. 137-148
    • Wolfe, F.1
  • 4
    • 0028890678 scopus 로고
    • The prevalence and characteristics of fibromyalgia in the general population
    • Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28
    • (1995) Arthritis Rheum , vol.38 , pp. 19-28
    • Wolfe, F.1    Ross, K.2    Anderson, J.3
  • 7
  • 8
    • 68949186535 scopus 로고    scopus 로고
    • Medical care and APS-guideline-related prescription drug use in newly diagnosed and established fibromyalgia patients
    • White L, Birnbaum H, Kaltenboeck A, et al. Medical care and APS-guideline-related prescription drug use in newly diagnosed and established fibromyalgia patients. J Pain 2008;9:16
    • (2008) J Pain , vol.9 , pp. 16
    • White, L.1    Birnbaum, H.2    Kaltenboeck, A.3
  • 10
    • 77954848946 scopus 로고    scopus 로고
    • Patterns of pain-related pharmacotherapy in patients with fibromyalgia
    • Berger A, Martin S, Dukes E, et al. Patterns of pain-related pharmacotherapy in patients with fibromyalgia. Manag Care Interface 2008;20:30-8
    • (2008) Manag Care Interface , vol.20 , pp. 30-38
    • Berger, A.1    Martin, S.2    Dukes, E.3
  • 11
    • 53349153624 scopus 로고    scopus 로고
    • Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany
    • Berger A, Sadosky A, Dukes E, et al. Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin 2008;24:2489-99
    • (2008) Curr Med Res Opin , vol.24 , pp. 2489-2499
    • Berger, A.1    Sadosky, A.2    Dukes, E.3
  • 12
    • 77958118729 scopus 로고    scopus 로고
    • Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia
    • Gore M, Sadosky A, Zlateva G, et al. Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia. Am J Manag Care 2010;16:S144-53
    • (2010) Am J Manag Care , vol.16
    • Gore, M.1    Sadosky, A.2    Zlateva, G.3
  • 13
    • 77649271165 scopus 로고    scopus 로고
    • Clinical characteristics, pharmacother-apy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin
    • Gore M, Sadosky AB, Zlateva G, et al. Clinical characteristics, pharmacother-apy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin. Pain Pract 2009;9:363-74
    • (2009) Pain Pract , vol.9 , pp. 363-374
    • Gore, M.1    Sadosky, A.B.2    Zlateva, G.3
  • 15
    • 38049152731 scopus 로고    scopus 로고
    • Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss
    • White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008;50:13-24
    • (2008) J Occup Environ Med , vol.50 , pp. 13-24
    • White, L.A.1    Birnbaum, H.G.2    Kaltenboeck, A.3
  • 17
    • 33748149055 scopus 로고    scopus 로고
    • The incidence of fibromyalgia and its associated comorbidities: A population-based retrospective cohort study based on international classification of diseases, 9th revision codes
    • DOI 10.1097/01.rhu.0000221817.46231.18, PII 0012474320060600000005
    • Weir PT, Harlan GA, Nkoy FL, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol 2006;12:124-8 (Pubitemid 44314970)
    • (2006) Journal of Clinical Rheumatology , vol.12 , Issue.3 , pp. 124-128
    • Weir, P.T.1    Harlan, G.A.2    Nkoy, F.L.3    Jones, S.S.4    Hegmann, K.T.5    Gren, L.H.6    Lyon, J.L.7
  • 18
    • 31044446359 scopus 로고    scopus 로고
    • The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice
    • DOI 10.1002/art.21545
    • Hughes G, Martinez C, Myon E, et al. The impact of a diagnosis of fibromy-algia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006; 54:177-83 (Pubitemid 43122200)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.1 , pp. 177-183
    • Hughes, G.1    Martinez, C.2    Myon, E.3    Taieb, C.4    Wessely, S.5
  • 19
    • 77951457223 scopus 로고    scopus 로고
    • Clinical and economic characteristics of patients with fibromyalgia syndrome
    • Lachaine J, Beauchemin C, Landry PA. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin J Pain 2010;26:284-90
    • (2010) Clin J Pain , vol.26 , pp. 284-290
    • Lachaine, J.1    Beauchemin, C.2    Landry, P.A.3
  • 21
    • 67650345728 scopus 로고    scopus 로고
    • Epidemiology, costs, and the economic burden of fibromyalgia
    • Spaeth M. Epidemiology, costs, and the economic burden of fibromyalgia. Arthritis Res Ther 2009;11:117
    • (2009) Arthritis Res Ther , vol.11 , pp. 117
    • Spaeth, M.1
  • 22
    • 0037328609 scopus 로고    scopus 로고
    • Direct and indirect costs of fibromyalgia to patients and their families
    • DOI 10.1016/S1361-3111(02)00130-9
    • Wassem R, Hendrix TJ. Direct and indirect costs of fibromyalgia to patients and their families. J Orthop Nurs 2003;7:26-32 (Pubitemid 36267357)
    • (2003) Journal of Orthopaedic Nursing , vol.7 , Issue.1 , pp. 26-32
    • Wassem, R.1    Hendrix, T.J.2
  • 24
    • 74549155031 scopus 로고    scopus 로고
    • Burden of fibromyalgia and comparisons with osteoarthritis in the workforce
    • Kleinman N, Harnett J, Melkonian A, et al. Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med 2009; 51:1384-93
    • (2009) J Occup Environ Med , vol.51 , pp. 1384-1393
    • Kleinman, N.1    Harnett, J.2    Melkonian, A.3
  • 25
    • 0032944445 scopus 로고    scopus 로고
    • Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: The London fibromyalgia epidemiology study
    • DOI 10.1002/1529-0131(199901)42:1<76::AID-ANR10>3.0.CO;2-G
    • White KP, Speechley M, Harth M, et al. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 1999;42:76-83 (Pubitemid 29042573)
    • (1999) Arthritis and Rheumatism , vol.42 , Issue.1 , pp. 76-83
    • White, K.P.1    Speechley, M.2    Harth, M.3    Ostbye, T.4
  • 29
    • 70749141238 scopus 로고    scopus 로고
    • New York, NY: Pfizer Inc
    • Lyrica package insert. New York, NY: Pfizer Inc, 2007
    • (2007) Lyrica Package Insert
  • 30
    • 70749153802 scopus 로고    scopus 로고
    • Indianapolis, IN: Eli Lilly & Co
    • Cymbalta package insert. Indianapolis, IN: Eli Lilly & Co., 2008
    • (2008) Cymbalta Package Insert
  • 31
    • 70349358936 scopus 로고    scopus 로고
    • New York, NY: Forest Pharmaceuticals, Inc
    • Savella package insert. New York, NY: Forest Pharmaceuticals, Inc., 2009
    • (2009) Savella Package Insert
  • 32
    • 77952742362 scopus 로고    scopus 로고
    • Comparative efficacy and harms of dulox-etine, milnacipran, and pregabalin in fibromyalgia syndrome
    • Häuser W, Petzke F, Sommer C. Comparative efficacy and harms of dulox-etine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 2010; 11:505-21
    • (2010) J Pain , vol.11 , pp. 505-521
    • Häuser, W.1    Petzke, F.2    Sommer, C.3
  • 33
    • 43549113560 scopus 로고    scopus 로고
    • Long-term trials of pregabalin and duloxetine for fibromy-algia symptoms: How study designs can affect placebo factors
    • Staud R, Price DD. Long-term trials of pregabalin and duloxetine for fibromy-algia symptoms: how study designs can affect placebo factors. Pain 2008;136:232-4
    • (2008) Pain , vol.136 , pp. 232-234
    • Staud, R.1    Price, D.D.2
  • 34
    • 84856061431 scopus 로고    scopus 로고
    • Comparison of dosing patterns between fibro-myalgia patients with high versus low duloxetine or pregabalin compliance
    • Zhao Y, Sun P, Sun S, et al. Comparison of dosing patterns between fibro-myalgia patients with high versus low duloxetine or pregabalin compliance. Value Health 2010;13:A311
    • (2010) Value Health , vol.13
    • Zhao, Y.1    Sun, P.2    Sun, S.3
  • 35
    • 3543135271 scopus 로고    scopus 로고
    • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0. CO;2-B
    • D'Agostino Jr RB, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-81 (Pubitemid 28466823)
    • (1998) Statistics in Medicine , vol.17 , Issue.19 , pp. 2265-2281
    • D'Agostino Jr., R.B.1
  • 36
    • 77951622706 scopus 로고
    • The central role of the propensity score in observational studies for causal effects
    • Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55
    • (1983) Biometrika , vol.70 , pp. 41-55
    • Rosenbaum, P.1    Rubin, D.2
  • 37
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • DOI 10.1016/0021-9681(87)90171-8
    • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83 (Pubitemid 17055592)
    • (1987) Journal of Chronic Diseases , vol.40 , Issue.5 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.A.3    MacKenzie, C.R.4
  • 39
    • 4444381930 scopus 로고    scopus 로고
    • A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
    • DOI 10.1002/art.20485
    • Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50:2974-84 (Pubitemid 39209537)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.9 , pp. 2974-2984
    • Arnold, L.M.1    Lu, Y.2    Crofford, L.J.3    Wohlreich, M.4    Detke, M.J.5    Iyengar, S.6    Goldstein, D.J.7
  • 40
    • 49649095341 scopus 로고    scopus 로고
    • A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromy-algia
    • Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromy-algia. J Pain 2008;9:792-805
    • (2008) J Pain , vol.9 , pp. 792-805
    • Arnold, L.M.1    Russell, I.J.2    Diri, E.W.3
  • 41
    • 67649373629 scopus 로고    scopus 로고
    • A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibro-myalgia
    • Chappell AS, Bradley LA, Wiltse C, et al. A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibro-myalgia. Int J Gen Med 2009;1:91-102
    • (2009) Int J Gen Med , vol.1 , pp. 91-102
    • Chappell, A.S.1    Bradley, L.A.2    Wiltse, C.3
  • 42
    • 57649234533 scopus 로고    scopus 로고
    • Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
    • Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008; 30:1988-2004
    • (2008) Clin Ther , vol.30 , pp. 1988-2004
    • Clauw, D.J.1    Mease, P.2    Palmer, R.H.3
  • 43
    • 64849117499 scopus 로고    scopus 로고
    • The efficacy and safety of milna-cipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial
    • Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milna-cipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398-409
    • (2009) J Rheumatol , vol.36 , pp. 398-409
    • Mease, P.J.1    Clauw, D.J.2    Gendreau, R.M.3
  • 45
    • 33645709798 scopus 로고    scopus 로고
    • Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain
    • DOI 10.1111/j.1365-2354.2005.00624.x
    • Berger A, Dukes E, Mercadante S, et al. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care (Engl) 2006;15:138-45 (Pubitemid 43542755)
    • (2006) European Journal of Cancer Care , vol.15 , Issue.2 , pp. 138-145
    • Berger, A.1    Dukes, E.2    Mercadante, S.3    Oster, G.4
  • 46
    • 33845527581 scopus 로고    scopus 로고
    • Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline
    • DOI 10.1111/j.1533-2500.2006.00101.x
    • Gore M, Dukes E, Rowbotham D, et al. Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline. Pain Pract 2006;6:265-72 (Pubitemid 44920926)
    • (2006) Pain Practice , vol.6 , Issue.4 , pp. 265-272
    • Gore, M.1    Dukes, E.2    Rowbotham, D.3    Tai, K.-S.4    Leslie, D.L.5
  • 47
    • 57749193097 scopus 로고    scopus 로고
    • Antidepressants for the treatment of chronic pain
    • Please provide dates
    • Verdu B, Decosterd I, Buclin T, et al. Antidepressants for the treatment of chronic pain. Drugs 2008;68:2611-32AQ1 Please provide dates.
    • (2008) Drugs , vol.68
    • Verdu, B.1    Decosterd, I.2    Buclin, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.